Cashu
Eli Lilly Partners with Insilico Medicine for $2.75 Billion AI Drug Development Initiative
3 days ago
Stocks
Health Care
lly
Lilly(Eli) & Company
NYSE: LLY
+37.57 (+4.08%)
957.34
USD
At close at Apr 01, 16:34 UTC
Latest Lilly(Eli) & Company News
cnbc.com
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
about 1 hour ago
benzinga.com
Centessa Pharmaceuticals Agrees To Eli Lilly Acquisition At 40% Premium
about 2 hours ago
benzinga.com
Stock Of The Day: Where Will Eli Lilly Turn?
about 3 hours ago
benzinga.com
Eli Lilly Expands Into Sleep Medicine With Centessa Buyout
1 day ago
cnbc.com
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
1 day ago
cnbc.com
Wall Street's rough month, Powell's inflation outlook, GLP-1 subscription and more in Morning Squawk
1 day ago
cnbc.com
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly
1 day ago
prnewswire.com
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
1 day ago
cnbc.com
Oil's record month, TSA pay, the Pokmon card resale market and more in Morning Squawk
2 days ago
benzinga.com
Eli Lilly Secures $2.75 Billion Deal With Insilico Medicine To Bring AI-Developed Drugs To Global Market: Report
3 days ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.